Business
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
Boca Raton, Florida, March 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it will host a conference call on Thursday, March 27, 2025, at 4:30pm EDT to discuss results for its quarter ended December 31, 2024, and to provide a corporate update. Conference Call Information To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Please ask for the INmune
About this update from Inmune Bio Inc.
[{"type":"image","alt":"INmune Bio, Inc.","displaySize":"","headline":null,"caption":"INmune Bio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":82,"height":60,"url":"https://media.zenfs.com/en/globenewswire.com/b1e094e63c3b156eab453d7533cada9b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/ESFQnG17m_59Q1hSBmvAug--/YXBwaWQ9aGlnaGxhbmRlcjt3PTExMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/b1e094e63c3b156eab453d7533cada9b","width":82,"height":60}},"lazy":false},{"type":"text","content":"Boca Raton, Florida, March 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it will host a conference call on Thursday, March 27, 2025, at 4:30pm EDT to discuss results for its quarter ended December 31, 2024, and to provide a corporate update.","length":347,"tagName":"p"},{"type":"text","content":"Conference Call Information","length":27,"tagName":"p"},{"type":"text","content":"To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call. Please ask for the INmune Bio Third Quarter Conference Call when reaching the operator.","length":186,"tagName":"p"},{"type":"text","content":"Date: March 27, 2025","length":20,"tagName":"p"},{"type":"text","content":"Time: 4:30 PM Eastern Time","length":26,"tagName":"p"},{"type":"text","content":"Participant Dial-in: 1-800-225-9448 or 1-203-518-9708","length":53,"tagName":"p"},{"type":"text","content":"Conference ID: INMUNE","length":21,"tagName":"p"},{"type":"text","content":"A live audio webcast of the call can be accessed by clicking here or using this link:","length":85,"tagName":"p"},{"type":"text","content":"https://viavid.webcasts.com/starthere.jsp?ei=1704589&tp_key=4727e947f4","length":74,"tagName":"p"},{"type":"text","content":"A transcript will follow approximately 24 hours from the scheduled call. A replay will also be available by calling 1-844-512-2921 or 1-412-317-6671","length":148,"tagName":"p"},{"type":"text","content":"About INmune Bio Inc.","length":21,"tagName":"p"},{"type":"text","content":"INmune Bio Inc. is a publicly traded (NASDAQ: INMB), clinical-stage biotechnology company focused on developing treatments that target the innate immune system to fight disease. INmune Bio has three product platforms: the Dominant-Neg...